Remedy Plan Therapeutics to Showcase Novel NAMPT Inhibitor During Oral Presentation at 2023 American Society of Hematology (ASH) Annual Meeting
/PRNewswire/ -- Remedy Plan Therapeutics ("Remedy Plan"), a small molecule therapeutics start-up company transforming the field of NAMPT inhibition, today...
United States San Diego Parisa Moghaddam Taaheri Greg Crimmins American Society Of Hematology Remedy Plan
Source: prnewswire.com